MGR University - BSc Cardiac Technology - 3rd Year
Paper II: Cardiac Catheterization Laboratory - Advanced
Complete Chapter-wise Notes with Answers
CHAPTER 1: Aortic and Peripheral Angiography
Q1. Describe aortic angiography - aortic root, arch, and abdominal aorta.
Answer:
Purpose of Aortic Angiography:
- Evaluate aortic regurgitation
- Assess aortic aneurysm, dissection, coarctation
- Visualize arch vessels (carotid, subclavian)
- Pre-TAVI assessment
Catheter used: Pigtail catheter (6F-7F) - multiple side holes for high-volume injection
A. Aortic Root Angiography:
- Catheter placed just above aortic valve (in sinus of Valsalva level)
- Views: LAO 45-60° or RAO 30° (to separate aortic cusps)
- Injection: 40-60 mL at 20-25 mL/sec
- Shows: Aortic valve, sinuses of Valsalva, origin of coronary arteries, degree of aortic regurgitation (AR graded 1+ to 4+)
AR Grading on Aortogram:
| Grade | Description |
|---|
| 1+ | Faint opacification of LV, clears each beat |
| 2+ | Moderate LV opacification, less dense than aorta |
| 3+ | LV equally opaque as aorta |
| 4+ | LV more opaque than aorta on first beat |
B. Aortic Arch Angiography:
- Catheter placed in mid-ascending aorta or arch
- View: LAO 30-45° (to open up the arch)
- Injection: 40-50 mL at 20 mL/sec
- Shows: Arch anatomy, origin of brachiocephalic, left common carotid, left subclavian arteries; used to detect arch anomalies, dissection flap
C. Abdominal Aorta Angiography:
- Catheter placed at T12-L1 level (just above renal arteries)
- View: AP (anteroposterior); lateral view for renal artery origins
- Injection: 30-40 mL at 15-20 mL/sec
- Shows: Renal arteries, mesenteric arteries, iliac bifurcation, aortoiliac occlusive disease, abdominal aortic aneurysm (AAA)
Q2. What is peripheral angiography? What is CO₂ angiography?
Answer:
Peripheral Angiography:
- Visualization of arteries of lower limbs (iliac, femoral, popliteal, tibial, pedal) or upper limbs
- Indications: peripheral arterial disease (PAD), critical limb ischemia, claudication, pre-amputation assessment
- Access: femoral artery (contralateral), brachial, or radial
- Iodinated contrast injected; images taken sequentially as contrast flows distally (run-off films)
- Used to plan angioplasty, stenting, or bypass surgery
CO₂ (Carbon Dioxide) Angiography:
- CO₂ gas used as contrast agent instead of iodinated contrast
- Indications:
- Patients with severe contrast allergy
- Severe renal failure (prevents contrast nephropathy)
- CO₂ is completely absorbed by the body - no renal toxicity
- Technique: Special CO₂ delivery system used; imaging done immediately (CO₂ clears quickly)
- Limitations:
- Neurotoxic if used in brain/coronary vessels (NEVER use above diaphragm)
- Bowel gas artifact
- Poor image quality compared to iodinated contrast
- Need dedicated CO₂ delivery kit to avoid air contamination
CHAPTER 2: Contrast Agents
Q3. Classify contrast agents. Differentiate ionic vs non-ionic contrast agents.
Answer:
Classification of Contrast Agents:
- All iodinated contrast agents contain iodine (high atomic number = blocks X-rays)
| Property | Ionic (High Osmolar) | Non-Ionic (Low Osmolar) |
|---|
| Examples | Diatrizoate (Urografin), Ioxaglate (Hexabrix) | Iohexol (Omnipaque), Iodixanol (Visipaque), Iopamidol |
| Osmolality | 1500-1800 mOsm/kg (5-8× blood) | 600-800 mOsm/kg (2-3× blood) |
| Charge | Ionize in solution (carry charge) | Do not ionize (neutral) |
| Cost | Cheap | Expensive |
| Side effects | More: nausea, arrhythmia, bradycardia, pain, nephrotoxicity | Less: better tolerated |
| Viscosity | Lower | Higher (especially iodixanol - iso-osmolar) |
| Use in cath lab | Rarely used now | Standard choice for coronary/LV angiography |
Types of Non-Ionic agents:
- Low osmolar (LOCM): Iohexol, Iopamidol, Ioversol
- Iso-osmolar (IOCM): Iodixanol (Visipaque) - same osmolality as blood (290 mOsm/kg) - least nephrotoxic
Contrast concentration used:
- Coronary angiography: 300-350 mg iodine/mL
- LV/Aortography: 350-370 mg iodine/mL
- Peripheral angiography: 150-250 mg iodine/mL (diluted)
Q4. What is contrast nephropathy? How is it prevented?
Answer:
Definition:
Contrast-Induced Nephropathy (CIN) = rise in serum creatinine by ≥0.5 mg/dL or ≥25% from baseline within 48-72 hours after contrast administration, in the absence of another cause.
Pathophysiology:
- Direct tubular toxicity of contrast
- Renal vasoconstriction → decreased renal blood flow → ischemia
- Free radical generation → oxidative stress to tubular cells
Risk Factors:
- Pre-existing chronic kidney disease (CKD) - most important
- Diabetes mellitus
- Dehydration
- Large volume of contrast
- Nephrotoxic drugs (NSAIDs, aminoglycosides)
- Multiple contrast exposures within 24-48 hrs
- Heart failure, hypotension
Prevention:
| Method | Detail |
|---|
| IV Hydration | Normal saline 1 mL/kg/hr for 12 hrs before and after - MOST important |
| Use minimum contrast | Smallest volume needed; use diluted contrast when possible |
| Use iso-osmolar contrast | Iodixanol preferred in high-risk patients |
| N-Acetylcysteine | 600 mg twice daily day before and day of procedure (evidence controversial but still used) |
| Hold nephrotoxic drugs | Stop NSAIDs, aminoglycosides 48 hrs before |
| Avoid Metformin | Hold metformin 48 hrs before (risk of lactic acidosis if AKI develops) |
| Consider CO₂ angiography | In very high-risk patients |
| Sodium bicarbonate | IV bicarbonate drip in some protocols |
Normal creatinine: 0.6-1.2 mg/dL
CIN usually resolves in 1-3 weeks; rarely causes permanent dialysis-dependent renal failure.
CHAPTER 3: Coronary Angioplasty (PTCA)
Q5. Describe the equipment and hardware used in PTCA/PCI.
Answer:
PTCA = Percutaneous Transluminal Coronary Angioplasty
PCI = Percutaneous Coronary Intervention (includes balloon + stent)
Equipment:
1. Guiding Catheters:
- Larger than diagnostic catheters (6F-8F), no taper at tip
- Provide backup support for device delivery
- Types: JL (Judkins Left), JR (Judkins Right), EBU (Extra Back-Up), XB, Amplatz
- Must provide coaxial alignment with coronary ostium
2. Guidewires:
- 0.014" diameter (much thinner than diagnostic 0.035" wire)
- Components: core wire + coil/jacket + tip
- Properties: torque control, flexibility, support
- Types:
- Workhorse wire (BMW, Runthrough) - for routine lesions
- Stiff support wires (Amplatz Extra Support) - for calcified/tortuous vessels
- Hydrophilic wires - for chronic total occlusions
- Pressure wires (FFR wire, e.g., PressureWire) - for FFR measurement
3. Balloons:
- Semi-compliant balloons - standard; used for pre-dilatation
- Non-compliant (NC) balloons - for high-pressure post-dilatation of stents
- Scoring/cutting balloons - for resistant/calcified lesions
- Balloon sizes: 1.5-5.0 mm diameter; length 10-40 mm
- Inflated using indeflator device at controlled atmospheres (6-24 atm)
4. Stents:
- Metal scaffold that keeps artery open after balloon dilatation
- Bare Metal Stents (BMS): Stainless steel; restenosis rate ~20-30% at 1 year
- Drug Eluting Stents (DES): Coated with antiproliferative drug (Sirolimus, Paclitaxel, Everolimus); restenosis rate ~5-10%; need dual antiplatelet therapy (DAPT) for 12 months
- Bioresorbable Scaffolds (BRS): Dissolve over 2-3 years; fully absorbed
Setting up the lab for a PTCA case:
- 7F or 8F arterial sheath
- IV heparin bolus (70-100 units/kg to achieve ACT >250 sec)
- Guiding catheter selected
- Lesion assessed (TIMI flow, % stenosis)
- Wire crossed into distal vessel
- Balloon pre-dilated lesion
- Stent deployed at 10-14 atm
- Post-dilated with NC balloon
- Final angiogram to confirm result (TIMI 3 flow, <30% residual stenosis)
Q6. What are the complications of PTCA and their management?
Answer:
A. Slow Flow / No Reflow:
- Definition: Loss of coronary flow after intervention despite no dissection or thrombosis
- Cause: Distal embolization of plaque/thrombus, microvascular spasm
- Management:
- Intracoronary adenosine (100-200 mcg)
- Intracoronary nitroprusside (100-200 mcg)
- Intracoronary verapamil (100-200 mcg)
- GP IIb/IIIa inhibitors (abciximab, eptifibatide)
- Aspiration thrombectomy if thrombus
B. Acute Stent Thrombosis:
- Definition: Thrombus within stent within 24 hours of implantation
- Presentation: Sudden chest pain, ST elevation, hemodynamic compromise
- Causes: Stent underexpansion, dissection at edge, poor antiplatelet coverage, clopidogrel resistance
- Management:
- Emergency repeat angiogram
- Balloon re-dilatation, repeat stenting
- IV heparin + GP IIb/IIIa inhibitor
- Ensure DAPT (aspirin + ticagrelor/prasugrel)
C. Coronary Dissection:
- Definition: Tear in coronary artery wall by guidewire or balloon
- NHLBI Classification: Type A-F (F = spiral dissection with total occlusion)
- Management:
- Type A-C: Often conservative if flow maintained
- Type D-F: Stent to seal the dissection (bail-out stenting)
- If no-reflow persists: IABP support, emergency CABG
D. Coronary Perforation:
- Rare but life-threatening: Wire or balloon exits the vessel wall
- Presentation: Chest pain, pericardial effusion, tamponade
- Management:
- Prolonged balloon inflation to seal perforation
- Covered stent (PTFE-covered)
- Pericardiocentesis for tamponade
- Emergency surgery if severe
CHAPTER 4: Pediatric Interventions
Q7. Describe pediatric cardiac interventions - aortic/pulmonary valvuloplasty, coarctation stenting, device closure of PDA/ASD/VSD.
Answer:
A. Balloon Aortic Valvuloplasty (BAV):
- Indication: Congenital aortic stenosis with gradient >50 mmHg
- Technique: Retrograde approach via femoral artery; balloon passed across aortic valve; inflated to split fused commissures
- Balloon size: 80-90% of aortic annulus diameter
- Complication: Aortic regurgitation (most feared)
B. Balloon Pulmonary Valvuloplasty (BPV):
- Indication: Pulmonary stenosis with gradient >40-50 mmHg
- Technique: Antegrade via femoral vein → RA → RV → balloon across pulmonary valve
- Balloon size: 120-140% of pulmonary annulus
- Results: Excellent; gradient usually falls by >50%
- Complication: Pulmonary regurgitation (usually mild and well-tolerated)
C. Coarctation Angioplasty and Stenting:
- Indication: Coarctation of aorta with gradient >20 mmHg or >50% narrowing
- Technique: Balloon angioplasty in neonates/infants; stenting preferred in older children/adults
- Stents: Covered stents (CP stent, Palmaz stent)
- Complication: Aortic dissection, aneurysm at coarctation site, re-coarctation
D. Device Closure of PDA (Patent Ductus Arteriosus):
- Indication: Significant PDA with L-R shunt (Qp:Qs >1.5)
- Devices: Amplatzer Duct Occluder (ADO), coils (Gianturco coil - for small PDAs)
- Technique: Catheter passed from femoral vein → RA → RV → PA → PDA; device deployed to occlude
- Sizing: Device chosen 2 mm larger than minimal PDA diameter
- Success rate: >95%; device embolization is the main complication
E. Device Closure of ASD (Atrial Septal Defect):
- Indication: Ostium secundum ASD, Qp:Qs >1.5, right heart volume overload
- Device: Amplatzer Septal Occluder (ASO) - double disc device
- Technique: Transseptal - catheter from femoral vein → IVC → RA → across ASD; device deployed with left disc in LA, right disc in RA
- Sizing: By TEE (transesophageal echo) or intracardiac echo; device = ASD diameter + 2-4 mm
- Must have adequate rim of ≥5 mm on all sides (except aortic rim)
F. Device Closure of VSD (Ventricular Septal Defect):
- Indication: Muscular VSDs, perimembranous VSDs in selected cases
- Device: Amplatzer Muscular VSD Occluder
- More complex - requires arteriovenous loop (femoral artery + femoral vein loop)
- Complication: AV block (perimembranous VSDs - proximity to conduction system)
G. Coil Closure of PDAs:
- Small PDAs (≤2.5 mm): Gianturco coils deployed via catheter
- Multiple coils may be needed
- Simpler and cheaper than Amplatzer device
- Risk: Coil embolization to PA
CHAPTER 5: Balloon Mitral Valvuloplasty (BMV)
Q8. Describe the technique and hardware used in Balloon Mitral Valvuloplasty (BMV).
Answer:
Indication: Symptomatic mitral stenosis (MVA <1.5 cm²) with favorable valve morphology (Wilkins score ≤8)
Wilkins Score (each component scored 1-4):
- Leaflet mobility
- Leaflet thickening
- Calcification
- Subvalvular thickening
- Score ≤8 = good candidate; >10 = poor candidate
Technique - Inoue Method (most common):
- Venous access - femoral vein, 8F sheath
- Transseptal puncture - Brockenbrough needle + Mullins sheath punctures interatrial septum (fossa ovalis) under fluoroscopy and echo guidance
- Enter LA - catheter advanced into LA; heparin given
- Position Inoue balloon - balloon catheter advanced over wire into LA; across mitral valve into LV
- Sequential balloon inflation:
- Distal portion inflated first (anchors in LV)
- Proximal portion inflated (anchors in LA)
- Waist (middle) inflated last - splits commissures
- Rapid inflation and deflation
- Assessment after each inflation - hemodynamics (gradient falls), echo (MR grade, MVA)
- Endpoint: MVA ≥1.5 cm² OR MR increases by >1 grade (stop)
(Above: A - Inoue balloon catheter fully inflated showing the characteristic bilobed shape; B - Fluoroscopic view of Inoue balloon inflated across the mitral valve)
Equipment:
- Inoue balloon catheter (self-positioning, stepwise inflation)
- Brockenbrough needle (curved, stainless steel) for transseptal puncture
- Mullins sheath (transseptal sheath)
- Pressure injector to measure transmitral gradient before and after
- TEE/ICE for guidance
Recording transmitral pressure gradients:
- Simultaneous LA pressure (via transseptal sheath) and LV pressure (via retrograde catheter or second transseptal)
- Mean gradient calculated: Normal <5 mmHg; severe MS >10 mmHg
- Gorlin formula for MVA: CO / (DFP × HR × 37.7 × √mean gradient)
Management of cardiac tamponade (complication of transseptal puncture):
- Sudden hypotension + pulsus paradoxus + JVP rise = suspect tamponade
- Urgent pericardiocentesis (subxiphoid approach, echo-guided)
- Reverse heparin with protamine
- Emergency surgery if bleeding doesn't stop
CHAPTER 6: Peripheral Interventions
Q9. Describe equipment, techniques, and stents used in peripheral vascular interventions.
Answer:
Indications:
- Peripheral arterial disease (PAD) - iliac, femoral, popliteal, tibial stenosis/occlusion
- Renal artery stenosis
- Carotid artery stenosis
- Subclavian artery stenosis
Equipment:
- Long sheaths (45-90 cm) to reach distal vessels
- Hydrophilic guidewires (0.035" or 0.018") for crossing lesions
- Angioplasty balloons (4-12 mm diameter, 40-200 mm length for peripheral vessels)
- Stents: Self-expanding (nitinol) or balloon-expandable
Types of Stents:
| Type | Material | Use |
|---|
| Self-expanding (Wallstent, Protégé) | Nitinol/stainless steel | Superficial femoral artery, carotid, iliac |
| Balloon-expandable (Palmaz) | Stainless steel | Renal artery, ostial iliac - precise placement needed |
| Covered stents (PTFE-covered) | Metal + polytetrafluoroethylene | Aneurysms, perforations, aortoiliac disease |
| Drug-coated balloons (DCB) | Paclitaxel-coated balloon | SFA lesions - reduces restenosis without leaving metal |
| Cutting balloons | Microsurgical blades | Resistant/calcified lesions |
Endovascular exclusion of aneurysms:
- Endovascular Aortic Repair (EVAR) for AAA
- Stent-graft deployed to exclude aneurysm sac from blood flow
- Landing zones must be free of thrombus (≥15 mm neck)
- Modular bifurcated grafts used for aortoiliac aneurysms
CHAPTER 7: Intra-Aortic Balloon Pump (IABP)
Q10. Explain the theory of IABP counterpulsation, indications, and setup.
Answer:
Principle - Counterpulsation:
IABP works by inflating during diastole and deflating during systole - opposite to cardiac cycle (hence "counter" pulsation).
Mechanism:
| Phase | What happens | Effect |
|---|
| Diastolic inflation | Balloon inflates in descending aorta | ↑ Diastolic pressure → ↑ Coronary perfusion (coronaries fill in diastole) |
| Systolic deflation | Balloon deflates just before systole | ↓ Afterload → LV ejects against less resistance → ↓ Myocardial O₂ demand |
Two key effects:
- Diastolic augmentation - increased coronary perfusion
- Systolic unloading (afterload reduction) - reduced LV workload
Indications:
- Cardiogenic shock (post-MI)
- Unstable angina refractory to medical therapy
- Mechanical complications of MI (acute MR, VSD)
- High-risk PCI support
- Bridge to surgery (CABG, valve surgery)
- Weaning from cardiopulmonary bypass
Contraindications:
- Aortic regurgitation (worsens AR)
- Aortic dissection
- Severe peripheral arterial disease (access problem)
- Aortic aneurysm
Setting up the IABP:
- Access: Femoral artery via Seldinger technique (7F or 8F sheath)
- Balloon size selected (34-50 cc based on patient height)
- Balloon inserted; tip positioned in descending aorta just below left subclavian artery (verified by CXR - tip at carina/T2 level)
- Console connected; ECG or arterial pressure waveform used as trigger
- Timing: Inflation triggered at dicrotic notch (end systole); deflation at R wave
- Assist ratio: 1:1 (every beat), 1:2, or 1:3
- Unfractionated heparin infusion to prevent thrombosis
Waveform interpretation:
- Augmented diastolic pressure should be higher than systolic peak (good counterpulsation)
- If inflation early: truncates systole (bad)
- If inflation late: diastolic augmentation reduced
- If deflation early: no afterload reduction benefit
- If deflation late: increases afterload (harmful)
CHAPTER 8: Thromboembolic Disease
Q11. Describe indications and use of vena caval filters, thrombolysis, and thrombus aspiration.
Answer:
A. Venacaval (IVC) Filters:
- Placed in inferior vena cava to trap thromboemboli from lower limb DVT before they reach lungs
- Absolute indications:
- DVT/PE with contraindication to anticoagulation
- Recurrent PE despite adequate anticoagulation
- Relative indications: Massive PE after thrombolysis, free-floating IVC thrombus, high-risk patients (e.g., post-trauma, post-bariatric surgery)
- Types: Permanent (Greenfield filter) or retrievable (Günther Tulip, OptEase)
- Technique: Femoral vein or jugular vein access; filter deployed below renal veins in infrarenal IVC
B. Techniques of Thrombolysis:
- Systemic thrombolysis: IV tPA (alteplase), streptokinase - for massive PE
- Catheter-directed thrombolysis (CDT): Catheter placed directly into thrombus; local infusion of tPA (0.5-1 mg/hr) over 12-24 hrs - for iliofemoral DVT or submassive PE
- Drugs used:
- tPA (alteplase) - most common, fibrin-specific
- Streptokinase - older, non-fibrin specific, more allergic reactions
- Urokinase - alternative
C. Thrombus Aspiration Systems:
Coronary thrombus aspiration:
- Manual aspiration catheters (Export catheter, Pronto catheter)
- Advanced over 0.014" wire into thrombus-laden coronary vessel
- Manual syringe suction applied while slowly withdrawing
- Used in STEMI with large thrombus burden to prevent distal embolization
Peripheral thrombus aspiration:
- AngioJet system - uses Bernoulli effect; high-velocity saline jets create suction to fragment and aspirate thrombus
- Penumbra system - mechanical aspiration for large vessel thrombosis
CHAPTER 9: Cardiac Pacing
Q12. Describe temporary and permanent pacing - indications, technique, types.
Answer:
A. Temporary Pacing:
Indications:
- Complete heart block (CHB) - acute or reversible
- Symptomatic bradycardia not responding to atropine
- Post-cardiac surgery
- Bridge to permanent pacemaker implantation
- Drug toxicity (digoxin, beta-blocker)
Technique:
- Femoral vein or internal jugular vein access
- 5F or 6F temporary pacing lead (balloon-tipped or screw-in)
- Balloon inflated → floats into RV (or positioned under fluoroscopy)
- Lead tip positioned at right ventricular apex (RVA)
- Lead connected to external pacing box
- Parameters set:
- Rate: 60-80 bpm (or above intrinsic rate)
- Output: 3-5 mA (set at 2× threshold)
- Sensitivity: 2-3 mV
- Check: Capture threshold (lowest output producing QRS) and Sensing threshold
B. Permanent Pacing:
Indications:
- Symptomatic complete AV block (Stokes-Adams attacks)
- High-degree AV block (2nd degree Mobitz II, 3rd degree)
- Sick sinus syndrome (SSS) with symptoms
- Chronotropic incompetence
Types of Pacemakers (NBG code):
| Chamber Paced | Chamber Sensed | Response | Example |
|---|
| V (Ventricle) | V | I (Inhibit) | VVI - single chamber ventricular |
| A (Atrium) | A | I | AAI - single chamber atrial |
| D (Dual) | D | D (Dual) | DDD - dual chamber (physiological) |
| V | V | R (Rate responsive) | VVIR - rate adaptive |
Types of Leads:
- Passive fixation (tined leads) - hooks into RV trabeculae
- Active fixation (screw-in helix) - better stability, used in RV outflow tract, LV
Setting up the lab for permanent pacing:
- Left subclavian or cephalic vein puncture (sterile field)
- Lead(s) advanced under fluoroscopy to RV apex (ventricular lead) and RA appendage (atrial lead)
- Acute parameters checked (threshold, impedance, R-wave sensing)
- Acceptable values:
- Threshold: <1 V at 0.5 ms
- Impedance: 300-1000 ohms
- Sensing: R-wave >5 mV (ventricle), P-wave >2 mV (atrium)
- Pocket created in left pectoral area; generator connected and buried
Pacemaker parameter checking / Follow-up:
- Done with programmer (manufacturer-specific)
- Check: battery voltage, lead impedance, threshold, sensing, pacing percentage
- Battery life: typically 7-12 years
- Remote monitoring available with modern devices
CHAPTER 10: Cardiac Electrophysiology
Q13. Describe electrophysiology (EP) study - catheters, connections, equipment, and radiofrequency ablation.
Answer:
Purpose of EP Study:
- Diagnose mechanism of arrhythmia
- Locate accessory pathways (WPW syndrome)
- Assess AV node and His-Purkinje function
- Guide ablation therapy
Catheters used in EP Study:
| Catheter | Position | Purpose |
|---|
| High Right Atrium (HRA) | RA near SA node | Records atrial activity, paces RA |
| His Bundle | Tricuspid annulus | Records His bundle potential (AH and HV intervals) |
| Coronary Sinus (CS) | CS via RA | Records LA and LV basal activity |
| Right Ventricle (RV) | RV apex | Paces RV, records RV electrograms |
| Ablation catheter | Variable (mapped to arrhythmia source) | Mapping + RF energy delivery |
All catheters = 4F-7F, multi-electrode, connected to EP recording system.
Connection of Catheters during EP Study:
- Each catheter connects to dedicated channel on EP recorder (amplifier + filter)
- Signals filtered: Atrial/ventricular signals at 30-500 Hz; His bundle at 30-500 Hz
- Bipolar or unipolar recordings
- Intracardiac signals displayed alongside surface ECG (I, II, V1 minimum)
Equipment used in Arrhythmia Induction and Mapping:
- EP stimulator (programmable S1-S2-S3 protocol for arrhythmia induction)
- EP recording system (records all catheter signals simultaneously)
- 3D mapping systems:
- CARTO (Biosense Webster) - magnetic field-based
- EnSite NavX (Abbott) - electrical field-based
- Creates 3D electroanatomic map of heart; identifies arrhythmia substrate
- Isoproterenol infusion (to provoke arrhythmia that requires sympathetic tone)
Radiofrequency Ablation (RFA):
- Principle: RF energy (300-750 kHz) delivered from ablation catheter tip → resistive heating → coagulative necrosis of arrhythmia substrate
- Temperature: 50-60°C; creates lesion of 5-6 mm diameter, 3-4 mm depth
- Energy: 25-50 Watts, 30-60 seconds per application
- Irrigated-tip catheters (saline irrigation prevents charring; larger lesions)
Conditions treated by RFA:
- WPW syndrome (accessory pathway ablation)
- SVT (AVNRT - slow pathway ablation in AV node)
- Atrial flutter (cavotricuspid isthmus ablation)
- Atrial fibrillation (pulmonary vein isolation - PVI)
- VT (scar-based; substrate ablation)
Image Archival and CD Writing:
- All angiographic and EP data stored in DICOM format
- CATH lab: Cardiac cine images archived on DICOM server
- EP lab: EP tracings + 3D maps archived
- Data can be burned to CD/DVD for patient records
- PACS (Picture Archiving and Communication System) for institutional storage
EXAM TIPS - Paper II Important Questions
Long Essay Questions (10 marks):
- Explain PTCA - hardware, technique, complications and management
- Describe IABP - principle, indications, setup, waveform interpretation
- Explain Balloon Mitral Valvuloplasty - technique, equipment, transseptal puncture
- Describe cardiac electrophysiology study and radiofrequency ablation
- Describe permanent pacemaker implantation - types, technique, follow-up
Short Notes (5 marks):
- Contrast nephropathy - prevention
- Ionic vs non-ionic contrast
- CO₂ angiography
- Temporary cardiac pacing
- Device closure of ASD / PDA
- Stent thrombosis management
- Aortic regurgitation grading on aortogram
- No-reflow phenomenon
- IVC filter - indications and types
- CARTO mapping system
Short Answers (3 marks):
- Inoue balloon
- Wilkins score
- NBG pacemaker code
- RF ablation principle
- CO₂ angiography contraindication
- CIN definition
- Stent types (BMS vs DES)
- Guidewire diameter for PTCA
- IABP trigger
- Self-expanding vs balloon-expandable stents
Sources: Braunwald's Heart Disease; Fuster & Hurst's The Heart 15th Ed.; Harrison's IM 22nd Ed.; Tintinalli's Emergency Medicine; MGR University Official Syllabus - Paper II: Cardiac Catheterization Laboratory Advanced.
All topics from the MGR University Paper II syllabus are now fully covered. Use Paper I notes + Paper II notes together for complete 3rd year exam preparation. All the best! 💪